Zacks.com featured highlights include Neurocrine Biosciences, MYR Group, Block, Delek US Holdings and Dycom Industries

For Immediate ReleaseChicago, IL – July 2, 2026 – Stocks in this week’s article are Neurocrine Biosciences NBIX, MYR Group MYRG, Block XYZ, Delek US Holdings DK and Dycom Industries DY.5 Relative Price Strength Stocks to Buy for the Second Half of 2026The U.S. stock market enters the second half of 2026 on a solid footing, supported by resilient economic growth, healthy corporate earnings and easing geopolitical tensions. While the Federal Reserve has adopted a more hawkish stance and investors are weighing the possibility of another interest-rate hike, cooling oil prices and steady consumer spending remain reasons for optimism.Market leadership has also started to broaden beyond the artificial intelligence-driven rally, with defensive sectors such as healthcare and consumer staples attracting fresh interest. This rotation reflects a healthier market rather than a weakening one, as investors look for companies with stable earnings and strong fundamentals. In this environment, focusing on stocks showing strong relative price strength can be an effective strategy, as they often continue to outperform even when market leadership shifts.At this stage, investors would be wise to consider companies, such as Neurocrine Biosciences, MYR Group, Block, Delek US Holdings and Dycom Industries.Relative Price Strength StrategyEarnings growth and valuation multiples are indeed important for investors to determine a stock's ability to offer considerable returns. However, these are also essential for determining whether a stock's price performance is better than its peers or the industry average.If a stock's performance is lacking that of the broader groups, despite impressive earnings growth or valuation multiples, then something must be wrong.It's always advisable to stay away from these stocks and bet on those that are outperforming their respective industry or benchmark. This is because betting on a winner always proves to be lucrative.Then again, it is imperative that you determine whether or not an investment has relevant upside potential when considering stocks with significant relative price strength. Stocks delivering better than the S&P 500 for 1 to 3 months, at least, and having solid fundamentals, indicate room for growth and the best way to go about this strategy.Finally, it is crucial to find out whether analysts are optimistic about the upcoming earnings of these companies. In order to do this, we have added positive estimate revisions for the current quarter's (Q1) earnings to our screen. When a stock undergoes an upward revision, it leads to additional price gains.Here are five of the 10 stocks that made it through the screen:Neurocrine Biosciences: Neurocrine Biosciences develops therapies for neurological, psychiatric, endocrine and immune disorders. Its marketed drugs, INGREZZA and CRENESSITY, drive growth, while a broad pipeline supports future treatment options.Over the past 60 days, the Zacks Consensus Estimate for the company's 2026 earnings has moved up 18.8%. NBIX has a VGM Score of A.Neurocrine Biosciences beat the Zacks Consensus Estimate for earnings in three of the last four quarters and missed in the other. It has a trailing four-quarter earnings surprise of roughly 6.9%, on average. NBIX shares have gained 31.7% in a year.MYR Group: MYR Group is a leading electrical construction company serving the United States and Canada. Through its Transmission & Distribution and Commercial & Industrial segments, it delivers power infrastructure, data center, transportation, healthcare and clean energy projects. The Zacks Consensus Estimate for MYR Group's 2026 earnings indicates 51.8% growth. MYRG has a VGM Score of B.The firm has a market capitalization of around $7.8 billion. Over the past 60 days, the Zacks Consensus Estimate for MYR Group's 2026 earnings has gone up 15.2%. MYRG's shares have surged 176.9% in a year.Block: Block offers financial and marketing services through a commerce ecosystem that helps sellers start, run and grow their businesses. The company's expected EPS growth rate for three to five years is currently 31.8%, which compares favorably with the industry's growth rate of 22.8%. XYZ has a VGM Score of A.Over the past 60 days, the Zacks Consensus Estimate for Block's 2026 earnings has moved up 13.8%. The Zacks Consensus Estimate for 2026 earnings of the company indicates 5% growth. XYZ shares have gained 11.3% in a year.Delek US Holdings: Brentwood, TN-based Delek US Holdings is an independent refiner, transporter and marketer of petroleum products. DK's expected EPS growth rate for three to five years is currently 29.4%, which compares favorably with the industry's growth rate of 25.5%. The company has a VGM Score of A.DK has a trailing four-quarter earnings surprise of roughly 215.8%, on average. Over the past 60 days, the Zacks Consensus Estimate for the downstream operator's 2026 earnings has moved up from $3.66 per share to $5.27. Delek's shares have gone up 133.8% in a year.Dycom Industries: Dycom is a specialty contracting firm operating in the telecom industry. It provides diverse services such as engineering, construction, maintenance and installation services for the cable and telephone companies. The Zacks Consensus Estimate for fiscal 2027 earnings of Dycom indicates 28.8% growth. DY has a VGM Score of B.Over the past 60 days, the Zacks Consensus Estimate for Dycom's fiscal 2027 earnings has moved up 19.7%. The company has a market capitalization of $15.2 billion. DY shares have gone up 107% in a year.For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2946024/5-relative-price-strength-stocks-to-buy-for-the-second-halfDisclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.About Screen of the WeekZacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine.  But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.Strong Stocks that Should Be in the NewsMany are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.Follow us on Twitter:  https://www.twitter.com/zacksresearchJoin us on Facebook:  https://www.facebook.com/ZacksInvestmentResearchZacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.Contact: Jim GiaquintoCompany: Zacks.comPhone: 312-265-9268Email: pr@zacks.comVisit: https://www.zacks.com/Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>This article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks